Sinopharm Hyundai (600420.SH) obtained drug registration certificate for bryprazole tablets

Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for bryprazole tablets approved and issued by the State Drug Administration. Briprazole tablets are an oral atypical antipsychotic, mainly used to treat schizophrenia in adults. The drug modulates neurotransmitters in the brain through multiple mechanisms such as partially stimulating dopamine D2 receptors and 5-HT1A receptors, and antagonizing 5-HT2A receptors, thereby improving psychotic symptoms.